{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:17:04Z","timestamp":1758824224187},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.spen.2010.10.006","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T09:49:42Z","timestamp":1293011382000},"page":"237-244","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacology in Childhood Arterial Ischemic Stroke"],"prefix":"10.1016","volume":"17","author":[{"given":"Catherine","family":"Amlie-Lefond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Cox","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2010.10.006_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/088307380001500508","article-title":"Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis","volume":"15","author":"deVeber","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/WNL.59.1.34","article-title":"Deaths from stroke in US children, 1979-98","volume":"59","author":"Fullerton","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2010.10.006_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1017\/S0012162200000852","article-title":"Outcome after ischaemic stroke in childhood","volume":"42","author":"Ganesan","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.2006-2791","article-title":"Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: The importance of cerebrovascular imaging","volume":"119","author":"Fullerton","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2010.10.006_bib5","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.105.583690","article-title":"Clinical and radiological recurrence after childhood arterial ischemic stroke","volume":"114","author":"Ganesan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.spen.2010.10.006_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0887-8994(02)00506-4","article-title":"Inherited and acquired risk factors and their combined effects in pediatric stroke","volume":"28","author":"Barreirinho","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(96)90434-1","article-title":"Activated protein C resistance in childhood stroke","volume":"347","author":"Ganesan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2010.10.006_bib8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.STR.31.6.1283","article-title":"Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children","volume":"31","author":"Kenet","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-0037-1614555","article-title":"Leiden, prothrombin 20210G\u2014>A and the MTHFR C677T mutations in childhood stroke","volume":"81","author":"McColl","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.spen.2010.10.006_bib10","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V94.11.3678","article-title":"Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood","volume":"94","author":"Nowak-Gottl","year":"1999","journal-title":"Blood"},{"issue":"suppl 3","key":"10.1016\/j.spen.2010.10.006_bib11","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1007\/PL00014336","article-title":"Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin","volume":"158","author":"Str\u00e4ter","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.spen.2010.10.006_bib12","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood.V80.8.1998.1998","article-title":"Maturation of the hemostatic system during childhood","volume":"80","author":"Andrew","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.spen.2010.10.006_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH05-01-0047","article-title":"Developmental haemostasis","volume":"95","author":"Monagle","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.spen.2010.10.006_bib14","first-page":"115","article-title":"The fibrinolytic system in newborns and children","volume":"52","author":"Parmar","year":"2006","journal-title":"Clin Lab"},{"key":"10.1016\/j.spen.2010.10.006_bib15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(09)70241-8","article-title":"Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: A multicentre, observational, cohort study","volume":"8","author":"Goldenberg","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2010.10.006_bib17","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2010.10.006_bib18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/WNL.55.11.1649","article-title":"Early stroke treatment associated with better outcome: The NINDS rt-PA stroke study","volume":"55","author":"Marler","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2010.10.006_bib19","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/01.STR.0000015555.21285.DB","article-title":"Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?","volume":"33","author":"Ringleb","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2006.12.011","article-title":"Safety of routine IV thrombolysis between 3 and 4.5 h after ischemic stroke","volume":"254","author":"Uyttenboogaart","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2010.10.006_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2010.10.006_bib22","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1161\/STROKEAHA.109.192535","article-title":"Expansion of the Time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association\/American Stroke Association","volume":"40","author":"del Zoppo","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib23","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1016\/j.febslet.2005.03.058","article-title":"Understanding the enzymology of fibrinolysis and improving thrombolytic therapy","volume":"579","author":"Longstaff","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.spen.2010.10.006_bib24","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/jcbfm.2008.14","article-title":"Thrombolytic agents in stroke: Molecular requirements for NMDA receptor-mediated neurotoxicity","volume":"28","author":"Lopez-Atalaya","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.spen.2010.10.006_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(08)70267-9","article-title":"Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (Dias-2): A prospective, randomised, double-blind, placebo-controlled study","volume":"8","author":"Hacke","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib26","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/STROKEAHA.108.541185","article-title":"Thrombolysis in young adults with ischemic stroke","volume":"40","author":"Putaala","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(09)70106-1","article-title":"Use of alteplase in childhood arterial ischaemic stroke: A multicentre, observational, cohort study","volume":"8","author":"Amlie-Lefond","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib28","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","article-title":"Management of stroke in infants and children: A scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the young","volume":"39","author":"Roach","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-0038-1646972","article-title":"Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers","volume":"60","author":"Siegbahn","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.spen.2010.10.006_bib30","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2010.10.006_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke","volume":"29","author":"Del Zoppo","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/STROKEAHA.108.529560","article-title":"Thrombolysis in childhood stroke: Report of 2 cases and review of the literature","volume":"40","author":"Arnold","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0883073807300296","article-title":"Intra-arterial thrombolysis in a 2 year old with cardioembolic stroke","volume":"22","author":"Benedict","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1385\/NCC:2:2:179","article-title":"Intra-arterial thrombolysis of a distal internal carotid artery occlusion in an adolescent","volume":"2","author":"Bourekas","year":"2005","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.spen.2010.10.006_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/08830738030180060301","article-title":"Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl","volume":"18","author":"Golomb","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib36","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1212\/WNL.54.8.1684","article-title":"Intra-arterial thrombolysis for the treatment of perioperative childhood cardioembolic stroke","volume":"54","author":"Gruber","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2010.10.006_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1469-8749.2008.03232.x","article-title":"Local intra-arterial thrombolysis in a 4-year-old male with vertebrobasilar artery thrombosis","volume":"51","author":"Janmaat","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib38","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1542\/peds.112.3.e248","article-title":"Successful endovascular therapy for acute basilar thrombosis in an adolescent","volume":"112","author":"Kirton","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2010.10.006_bib39","first-page":"581","article-title":"Inhibition of vein graft intimal proliferative lesions in the rat by heparin","volume":"139","author":"Hirsch","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.spen.2010.10.006_bib40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.thromres.2005.11.004","article-title":"Age-related differences in heparin response","volume":"118","author":"Ignjatovic","year":"2006","journal-title":"Thromb Res"},{"issue":"suppl","key":"10.1016\/j.spen.2010.10.006_bib41","doi-asserted-by":"crossref","first-page":"258S","DOI":"10.1378\/chest.108.4_Supplement.258S","article-title":"Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"108","author":"Hirsh","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.spen.2010.10.006_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0887-8994(03)00270-4","article-title":"The use of enoxaparin in children with acute, nonhemorrhagic ischemic stroke","volume":"29","author":"Burak","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3476(96)70273-1","article-title":"Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study","volume":"128","author":"Massicotte","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2010.10.006_bib44","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1161\/STROKEAHA.109.550699","article-title":"Anticoagulation in childhood-onset arterial ischemic stroke with non-moyamoya arteriopathy: Findings from the Colorado and German (COAG) collaboration","volume":"40","author":"Bernard","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib45","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V94.9.3007","article-title":"Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients","volume":"94","author":"Streif","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.spen.2010.10.006_bib46","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI113239","article-title":"Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses","volume":"80","author":"Conway","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.spen.2010.10.006_bib47","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/hs1101.097379","article-title":"Aspirin versus low-dose low-molecular-weight heparin: Antithrombotic therapy in pediatric ischemic stroke patients: A prospective follow-up study","volume":"32","author":"Strater","year":"2001","journal-title":"Stroke"},{"issue":"suppl","key":"10.1016\/j.spen.2010.10.006_bib48","doi-asserted-by":"crossref","first-page":"887S","DOI":"10.1378\/chest.08-0762","article-title":"Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Monagle","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.spen.2010.10.006_bib49","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","article-title":"Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial","volume":"31","author":"Chen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib50","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1161\/circ.113.10.e409","volume":"113","author":"Sacco","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.spen.2010.10.006_bib51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/01.STR.0000162719.11058.bd","article-title":"Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregometry","volume":"36","author":"Harrison","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib52","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: A systematic review and meta-analysis","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.spen.2010.10.006_bib53","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1161\/01.STR.0000026500.24307.EA","article-title":"Aspirin versus low-molecular-weight heparin for ischemic stroke in children: An unanswered question","volume":"33","author":"deVeber","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib54","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1001\/jama.1989.03420170061031","article-title":"New epidemiologic evidence confirming that bias does not explain the aspirin\/Reye's syndrome Association","volume":"261","author":"Forsyth","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2010.10.006_bib55","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM199905063401801","article-title":"Reye's syndrome in the United States from 1981 through 1997","volume":"340","author":"Belay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2010.10.006_bib56","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.1988.03410050077033","article-title":"Reye's syndrome and aspirin","volume":"260","author":"Pinsky","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2010.10.006_bib57","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1542\/peds.66.6.859","article-title":"Reye's syndrome and salicylate use","volume":"66","author":"Starko","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2010.10.006_bib58","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/01.STR.0000209620.44017.97","article-title":"The risks and safety of clopidogrel in pediatric arterial ischemic stroke","volume":"37","author":"Soman","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.107.715821","article-title":"Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the platelet inhibition in children on clopidogrel (PICOLO) trial","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.spen.2010.10.006_bib60","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects","volume":"108","author":"Hulot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.spen.2010.10.006_bib61","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/CIRCULATIONAHA.109.851949","article-title":"Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes","volume":"119","author":"Mega","year":"2009","journal-title":"Circulation"},{"issue":"suppl","key":"10.1016\/j.spen.2010.10.006_bib62","doi-asserted-by":"crossref","first-page":"344S","DOI":"10.1378\/chest.119.1_suppl.344S","article-title":"Antithrombotic therapy in children","volume":"119","author":"Monagle","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.spen.2010.10.006_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2010.10.006_bib64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(83)80258-3","article-title":"Trial of low doses of aspirin as prophylaxis in sickle cell disease","volume":"102","author":"Greenberg","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2010.10.006_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000206360","article-title":"Treatment of sickle cell diseases with aspirin","volume":"72","author":"Zago","year":"1984","journal-title":"Acta Haematol"},{"key":"10.1016\/j.spen.2010.10.006_bib67","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: Rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.spen.2010.10.006_bib68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ana.10192","article-title":"Sickle cell disease: The neurological complications","volume":"51","author":"Prengler","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib69","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1542\/peds.2006-1241","article-title":"Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids","volume":"118","author":"Strouse","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2010.10.006_bib70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.pediatrneurol.2005.10.017","article-title":"Trials in sickle cell disease","volume":"34","author":"Kirkham","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib71","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1542\/peds.2008-0441","article-title":"Hydroxyurea for sickle cell disease: A systematic review for efficacy and toxicity in children","volume":"122","author":"Strouse","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2010.10.006_bib72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hoc.2009.11.002","article-title":"Hydroxyurea for children with sickle cell disease","volume":"24","author":"Heeney","year":"2010","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"10.1016\/j.spen.2010.10.006_bib73","first-page":"378","article-title":"Moyamoya syndrome: A surgically treatable cause of stroke in the pediatric patient","volume":"47","author":"Scott","year":"2000","journal-title":"Clin Neurosurg"},{"key":"10.1016\/j.spen.2010.10.006_bib74","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/088307389400900407","article-title":"Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood Moyamoya disease","volume":"9","author":"Hosain","year":"1994","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(85)91931-2","article-title":"Response of Moyamoya disease to verapamil","volume":"1","author":"McLean","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2010.10.006_bib76","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.STR.0000109766.27393.52","article-title":"Mechanism of ischemic infarct in spontaneous carotid dissection","volume":"35","author":"Benninger","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib77","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.STR.0000112970.63735.FC","article-title":"Antithrombotic drugs for carotid artery dissection","volume":"35","author":"Lyrer","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib78","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/STROKEAHA.107.489666","article-title":"Antiplatelets versus anticoagulation in cervical artery dissection","volume":"38","author":"Engelter","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3171\/PED\/2008\/2\/8\/101","article-title":"Extracranial traumatic carotid artery dissections in children: A review of current diagnosis and treatment options","volume":"2","author":"Chamoun","year":"2008","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.spen.2010.10.006_bib80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/08830738060210010101","article-title":"Craniocervical arterial dissection in children: Clinical and radiographic presentation and outcome","volume":"21","author":"Rafay","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib81","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1474-4422(09)70084-5","article-title":"Cervical-artery dissections: Predisposing factors, diagnosis, and outcome","volume":"8","author":"Debette","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2010.10.006_bib82","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1440-1754.2004.00407.x","article-title":"Arterial ischaemic stroke in children","volume":"40","author":"Barnes","year":"2004","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.spen.2010.10.006_bib83","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(02)11520-0","article-title":"Prospective assessment of risk factors for recurrent stroke during childhood\u2014A 5-year follow-up study","volume":"360","author":"Str\u00e4ter","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2010.10.006_bib84","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.STR.0000069017.78624.37","article-title":"Homocysteine and risk of recurrent stroke","volume":"34","author":"Boysen","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib85","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/01.CIR.99.16.2070","article-title":"Hyperhomocysteinemia: A risk factor for ischemic stroke in children","volume":"99","author":"Van","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.spen.2010.10.006_bib86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainresbull.2006.07.014","article-title":"Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C","volume":"71","author":"Sazci","year":"2006","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.spen.2010.10.006_bib87","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/CS20090142","article-title":"High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population","volume":"118","author":"Zhang","year":"2010","journal-title":"Clin Sci Lond"},{"key":"10.1016\/j.spen.2010.10.006_bib88","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/01.STR.0000086753.00555.0D","article-title":"Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: A Multicenter Case-Control Study in China","volume":"34","author":"Li","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib89","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/MPH.0b013e31802d3e8a","article-title":"Homocysteine, MTHFR C677T, vitamin B12, and folate levels in Thai children with ischemic stroke: A case-control study","volume":"28","author":"Sirachainan","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.spen.2010.10.006_bib90","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/STROKEAHA.108.529503","article-title":"Homocysteine-lowering therapy and stroke risk, severity, and disability: Additional findings from the HOPE 2 trial","volume":"40","author":"Saposnik","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2010.10.006_bib91","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (Visp) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2010.10.006_bib92","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.109.573410","article-title":"Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: A meta-analysis","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909110001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909110001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T15:43:46Z","timestamp":1685893426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909110001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1071909110001099"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2010.10.006","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}